Clinical Trial Update: Combination of Cabazitaxel With Prednisolone With Primary Prophylaxis With PEG-G-CSF in Treatment of Patients With Prostate Cancer [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating cabazitaxel plus prednisolone with primary prophylaxis using PEG-G-CSF in prostate cancer has completed. This update confirms the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Cabazitaxel (Jevtana) (cabazitaxel)
• PEG-G-CSF (pegylated granulocyte colony-stimulating factor)
• Prednisolone (Prednisolone)

Snippet

Sponsor: Sanofi | Conditions: Prostate Cancer | Phase 4 | Status: COMPLETED